Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Neural Therapeutics Inc. ( (TSE:NURL) ) just unveiled an update.
Neural Therapeutics Inc. has announced the opening of its partner Hanf.com’s 17th retail location in Freising, Bavaria, as part of its expansion strategy in Germany’s fast-growing CBD retail sector. This new store, strategically located near Munich, is expected to enhance Hanf.com’s market presence and financial efficiency while strengthening its reach into Munich and surrounding areas, thereby solidifying its position as a market leader.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is an ethnobotanical drug discovery company focused on developing therapeutic solutions for substance use disorders, including alcohol and opioid dependence. The company employs innovative approaches using sub-hallucinogenic doses of mescaline extract to enhance safety and scalability while maintaining therapeutic efficacy. Neural has entered into a strategic investment agreement with CWE European Holdings Inc., a leading CBD hemp retailer in Germany operating as Hanf.com, to potentially acquire up to 100% of CWE, aiming to expand its commercial footprint in Europe while continuing its focus on drug discovery and mental health innovation.
Average Trading Volume: 175,891
Technical Sentiment Signal: Strong Sell
See more insights into NURL stock on TipRanks’ Stock Analysis page.